FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for bicalutamide submitted by Viona Pharmaceuticals Inc., updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)